Literature DB >> 14604681

Solid-phase synthesis and biochemical evaluation of conformationally constrained analogues of deglycobleomycin A5.

Ali Cagir1, Zhi-Fu Tao, Steven J Sucheck, Sidney M Hecht.   

Abstract

Deglycobleomycin binds to and degrades the self-complementary oligonucleotide d(CGCTAGCG)(2) in a sequence selective fashion. A previous modeling study [J. Am. Chem. Soc. 120, (1998), 7450] had shown that, during binding to double stranded DNA, the conformation of the methylvalerate domain of deglycoBLM approximated that of S-proline. In the belief that an analogue of deglycoBLM structurally constrained to mimic the DNA-bound conformation might exhibit facilitated DNA binding and cleavage, an analogue of deglycoBLM was prepared in which the methylvalerate moiety was replaced by S-proline. This deglycoBLM analogue, as well as the related analogue containing R-proline, was synthesized on a TentaGel resin. Both of the analogues were found to be capable of binding Fe(2+) and activating O(2) for transfer to styrene. However, both deglycoBLM analogues exhibited diminished abilities to effect the relaxation of supercoiled plasmid DNA, and neither mediated sequence selective DNA cleavage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604681     DOI: 10.1016/j.bmc.2003.08.033

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Evaluating hydrophobic galactonoamidines as transition state analogs for enzymatic β-galactoside hydrolysis.

Authors:  Jessica B Pickens; Logan G Mills; Feng Wang; Susanne Striegler
Journal:  Bioorg Chem       Date:  2018-01-10       Impact factor: 5.275

2.  Picomolar inhibition of β-galactosidase (bovine liver) attributed to loop closure.

Authors:  Jessica B Pickens; Feng Wang; Susanne Striegler
Journal:  Bioorg Med Chem       Date:  2017-07-13       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.